日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Toxicities of novel androgen receptor pathway inhibitor targeted therapies in advanced prostate cancer

新型雄激素受体通路抑制剂靶向疗法在晚期前列腺癌中的毒性

Iaxx, Romain; Teyssonneau, Diego; Fallaha, Catherine; Grouthier, Virginie; Roubaud, Guilhem

Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response

对人肺腺癌中PD1、LAG3、TIGIT和TIM3表达的分析揭示了一个包含25个基因的特征谱,该特征谱可预测免疫治疗反应。

Guégan, Jean-Philippe; Peyraud, Florent; Dadone-Montaudie, Bérengère; Teyssonneau, Diego; Palmieri, Lola-Jade; Clot, Emma; Cousin, Sophie; Roubaud, Guilhem; Cabart, Mathilde; Leroy, Laura; Lebreton, Coriolan; Rey, Christophe; Lara, Oren; Odin, Ophélie; Brunet, Maxime; Vanhersecke, Lucile; Gruyters, Ezogelin Oflazoglu; Achour, Ikbel; Belcaid, Leila; Le Moulec, Sylvestre; Grellety, Thomas; Bessede, Alban; Italiano, Antoine

PARP inhibitors in prostate cancers, is it time for combinations?

PARP抑制剂在前列腺癌治疗中,是否应该考虑联合用药?

Teyssonneau, Diego; Dariane, Charles; Barret, Eric; Beauval, Jean-Baptiste; Brureau, Laurent; Fiard, Gaëlle; Fromont, Gaëlle; Créhange, Gilles; Gauthé, Mathieu; Ruffion, Alain; Renard-Penna, Raphaële; Mathieu, Romain; Sargos, Paul; Rouprêt, Morgan; Ploussard, Guillaume; Roubaud, Guilhem

Prostate cancer and PARP inhibitors: progress and challenges

前列腺癌与PARP抑制剂:进展与挑战

Teyssonneau, Diego; Margot, Henri; Cabart, Mathilde; Anonnay, Mylène; Sargos, Paul; Vuong, Nam-Son; Soubeyran, Isabelle; Sevenet, Nicolas; Roubaud, Guilhem

Cabazitaxel multiple rechallenges in metastatic castration-resistant prostate cancer

卡巴他赛在转移性去势抵抗性前列腺癌中的多次再治疗

Pobel, Cedric; Auclin, Edouard; Teyssonneau, Diego; Laguerre, Brigitte; Cancel, Mathilde; Boughalem, Elouen; Noel, Johanna; Brachet, Pierre Emmanuel; Maillet, Denis; Barthelemy, Philippe; Helissey, Carole; Thibault, Constance; Oudard, Stéphane